Intellectus Partners LLC Sells 595 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Intellectus Partners LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 5.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,739 shares of the exchange traded fund’s stock after selling 595 shares during the quarter. Intellectus Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,061,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of XBI. Quintet Private Bank Europe S.A. bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth $40,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter valued at about $40,000. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $44,000. Waldron Private Wealth LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth about $54,000. Finally, Resources Management Corp CT ADV lifted its position in shares of SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 3.0 %

Shares of NYSEARCA:XBI opened at $96.96 on Friday. The company has a market cap of $7.39 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50 day moving average price of $99.04 and a 200 day moving average price of $95.99. SPDR S&P Biotech ETF has a twelve month low of $69.32 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.